Harvard Bioscience (HBIO) Price to Book (2010 - 2026)

Harvard Bioscience (HBIO) has reported Price to Book for 17 consecutive years, with 3.77 the latest figure, recorded in Q2 2026.

• On a quarterly basis, Price to Book rose 203.05% year-over-year to 3.77 in Q2 2026; TTM through Jun 2026 was 3.77, a 203.05% increase from a year earlier, with the FY2025 full-year figure at 2.18, up 48.59% from the prior year.
• Price to Book was 3.77 for Q2 2026 at Harvard Bioscience, up from 2.19 in the prior quarter.
• Over five years, Price to Book peaked at 3.77 in Q2 2026 and troughed at 1.25 in Q2 2025.
• A 5-year average of 2.21 and a median of 2.05 in 2025 frame the typical range for Price to Book.
• Across the five-year window, Price to Book tumbled 60.01% in 2022 and soared 203.05% in 2026, its largest moves.
• Over 5 years, Price to Book stood at 1.61 in 2022, then surged by 96.84% to 3.18 in 2023, then tumbled by 53.79% to 1.47 in 2024, then surged by 48.59% to 2.18 in 2025, then jumped by 73.0% to 3.77 in 2026.
• The last three Price to Book figures came in at 3.77 (Q2 2026), 2.19 (Q1 2026), and 2.18 (Q4 2025), per Business Quant data.